The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial

The Journal of Clinical Psychiatry
Shaila MisriLisa Milis

Abstract

Approximately 10% to 16% of women experience a major depressive episode after childbirth. A significant proportion of these women also suffer from comorbid anxiety disorders. The purpose of this study was to evaluate whether the addition of cognitive-behavioral therapy (CBT) to standard antidepressant therapy offers additional benefits in the treatment of post-partum depression with comorbid anxiety disorders. Thirty-five women referred to a tertiary care hospital outpatient program with a DSM-IV diagnosis of postpartum depression with comorbid anxiety disorder were randomly assigned to 1 of 2 treatment groups-paroxetine-only monotherapy group (N = 16) or paroxetine plus 12 sessions of CBT combination therapy group (N = 19)-for a 12-week trial. Progress was monitored by a psychiatrist blinded to treatment group, using the Hamilton Rating Scale for Depression, Hamilton Rating Scale for Anxiety, Yale-Brown Obsessive Compulsive Scale, Clinical Global Impressions scale, and Edinburgh Postnatal Depression Scale. Data were analyzed using 2-tailed statistical tests at an alpha level of.05. The study was conducted from April 1, 2002, to June 30, 2003. Both treatment groups showed a highly significant improvement (p <.01) in mood and an...Continue Reading

Citations

Aug 26, 2006·Archives of Women's Mental Health·T B PearlsteinM Howard
Aug 22, 2009·Archives of Women's Mental Health·Rhiannon MulcahyCathy Owen
Mar 30, 2006·The American Journal of Orthopsychiatry·Shaila MisriSharita Shah
Nov 13, 2004·Journal of Clinical Psychopharmacology·Shaila Misri, Lisa Milis
Mar 14, 2007·Current Opinion in Obstetrics & Gynecology·Wing Hung Tam, Tony Chung
Nov 17, 2007·Current Opinion in Obstetrics & Gynecology·Elizabeth Shaw, Janusz Kaczorowski
Aug 8, 2009·Clinical Obstetrics and Gynecology·Sona Dimidjian, Sherryl Goodman
Aug 29, 2012·Journal of Clinical Psychopharmacology·Shaila MisriDeirdre Ryan
Sep 7, 2007·The Journal of ECT·Ariadna Forray, Robert B Ostroff
Jun 29, 2012·Journal of Physiological Anthropology·Shannon K Crowley, Shawn D Youngstedt
Feb 23, 2011·International Journal of Women's Health·Elizabeth FitelsonKristin Leight
Nov 1, 2013·Psychopharmacology·Liisa HantsooC Neill Epperson
Feb 12, 2013·Annual Review of Clinical Psychology·Michael W O'Hara, Jennifer E McCabe
Nov 28, 2012·Women's Health·Alkistis SkalkidouInger Sundström Poromaa
Sep 16, 2006·Journal of Clinical Psychopharmacology·Shaila MisriKristin Kendrick
Nov 5, 2010·International Review of Psychiatry·Kristin L LeightKatherine L Wisner
May 12, 2007·Expert Review of Neurotherapeutics·Henri Chabrol, Stacey Callahan
Oct 31, 2009·Expert Opinion on Pharmacotherapy·Teresa Lanza di Scalea, Katherine L Wisner
Oct 4, 2005·Expert Opinion on Pharmacotherapy·Oleg V Tcheremissine, Lori M Lieving
Nov 19, 2011·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·Brittany B SpeismanJonathan S Abramowitz
May 7, 2011·Clinical Psychology Review·Laura E SockolJacques P Barber
Aug 14, 2009·Journal of Affective Disorders·Raymond W LamUNKNOWN Canadian Network for Mood and Anxiety Treatments (CANMAT)
Jul 9, 2014·Obstetrics and Gynecology·Marian S McDonaghJeanne-Marie Guise
Sep 2, 2008·Obstetrics and Gynecology Clinics of North America·Emily C Dossett
Feb 15, 2008·Infant Behavior & Development·Tiffany Field
Jan 25, 2008·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Dwenda GjerdingenDeborah E Rich
Dec 28, 2007·Journal of Clinical Psychology·Pim CuijpersAnnemieke van Straten
Dec 26, 2006·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Anick BérardDriss Oraichi
Apr 5, 2012·Clinical Psychology & Psychotherapy·Scott Stuart
Aug 28, 2010·Pharmacotherapy·Rosalyn C NgPatrick R Finley
Feb 5, 2013·Journal of Midwifery & Women's Health·Denise BevanAdrian Wells
Sep 8, 2011·Depression and Anxiety·M Cynthia LogsdonStephen R Wisniewski
Oct 18, 2013·Journal of Midwifery & Women's Health·Constance GuilleC Neill Epperson
Feb 6, 2014·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Pim CuijpersCharles F Reynolds
Aug 20, 2009·Depression and Anxiety·Marlene P Freeman, Melinda F Davis
Oct 15, 2009·Journal of Clinical Psychology·Michael W O'Hara
Jun 23, 2010·Bipolar Disorders·Verinder Sharma, Mustaq Khan
Aug 26, 2006·Prostaglandins, Leukotrienes, and Essential Fatty Acids·M P Freeman
Oct 26, 2005·Midwifery·Jane Hanley, Barrie Long
Jun 19, 2013·Journal of Clinical Epidemiology·Shanil EbrahimGordon H Guyatt
Feb 6, 2015·Archives of Women's Mental Health·Sheryl M GreenRandi E McCabe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved